356 related articles for article (PubMed ID: 3305792)
1. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
[TBL] [Abstract][Full Text] [Related]
2. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
[TBL] [Abstract][Full Text] [Related]
5. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
[TBL] [Abstract][Full Text] [Related]
6. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
[TBL] [Abstract][Full Text] [Related]
7. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
Philip T; Ladenstein R; Zucker JM; Pinkerton R; Bouffet E; Louis D; Siegert W; Bernard JL; Frappaz D; Coze C
Br J Cancer; 1993 Jan; 67(1):119-27. PubMed ID: 8427772
[TBL] [Abstract][Full Text] [Related]
8. Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation.
Hartmann O; Valteau-Couanet D; Benhamou E; Vassal G; Rubie H; Beaujean F; Lemerle J
Eur J Cancer; 1997 Oct; 33(12):2126-9. PubMed ID: 9516867
[TBL] [Abstract][Full Text] [Related]
9. Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients.
Zucker JM; Philip T; Bernard JL; Michon J; Bouffet E; Gentet JC; Lopez M; Coze C; Philip I
Bone Marrow Transplant; 1991; 7 Suppl 2():91. PubMed ID: 1878739
[No Abstract] [Full Text] [Related]
10. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
Kushner BH; LaQuaglia MP; Bonilla MA; Lindsley K; Rosenfield N; Yeh S; Eddy J; Gerald WL; Heller G; Cheung NK
J Clin Oncol; 1994 Dec; 12(12):2607-13. PubMed ID: 7527454
[TBL] [Abstract][Full Text] [Related]
11. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK
Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368
[TBL] [Abstract][Full Text] [Related]
12. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
Matthay KK; Atkinson JB; Stram DO; Selch M; Reynolds CP; Seeger RC
J Clin Oncol; 1993 Nov; 11(11):2226-33. PubMed ID: 8229138
[TBL] [Abstract][Full Text] [Related]
13. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.
Nitschke R; Smith EI; Altshuler G; Altmiller D; Shuster J; Green A; Castleberry R; Hayes FA; Golembe B; Ducos R
J Clin Oncol; 1991 Jul; 9(7):1181-8. PubMed ID: 2045858
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.
Philip T; Bernard JL; Zucker JM; Pinkerton R; Lutz P; Bordigoni P; Plouvier E; Robert A; Carton R; Philippe N
J Clin Oncol; 1987 Feb; 5(2):266-71. PubMed ID: 3543245
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.
Valteau-Couanet D; Le Deley MC; Bergeron C; Ducassou S; Michon J; Rubie H; Le Teuff G; Coze C; Plantaz D; Sirvent N; Bouzy J; Chastagner P; Hartmann O
Pediatr Blood Cancer; 2014 Jun; 61(6):977-81. PubMed ID: 23970413
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma.
Corbett R; Pinkerton R; Pritchard J; Meller S; Lewis I; Kingston J; McElwain T
Eur J Cancer; 1992; 28A(8-9):1324-8. PubMed ID: 1515243
[TBL] [Abstract][Full Text] [Related]
17. [Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma].
Berthold F; Bender-Götze C; Dopfer R; Erttmann R; Haas RJ; Henze G; Körbling M; Riehm H; Rister M; Stollmann B
Klin Padiatr; 1988; 200(3):221-5. PubMed ID: 3062259
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
[TBL] [Abstract][Full Text] [Related]
19. A single center experience with bone marrow transplantation for high risk neuroblastoma.
Ladenstein R; Lasset C; Bouffet E; Brunat-Mentigny M; Biron P; Philip I; Chauvin F; Philip T
Bone Marrow Transplant; 1991; 7 Suppl 2():93. PubMed ID: 1878741
[No Abstract] [Full Text] [Related]
20. Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
De Ioris MA; Castellano A; Ilari I; Garganese MC; Natali G; Inserra A; De Vito R; Ravà L; De Pasquale MD; Locatelli F; Donfrancesco A; Jenkner A
Eur J Cancer; 2011 Mar; 47(4):572-8. PubMed ID: 21112775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]